Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 8.02M | $7.0M | 6.17% | -- | 2026-06-30 |
| Bvf Inc | 5.56M | $5.0M | 4.28% | -- | 2026-06-30 |
| Baker Bros. Advisors LP | 2.78M | $2.0M | 2.14% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 2.16M | $2.0M | 1.66% | +4.6K | 2026-06-30 |
| Two Sigma Investments, LP | 1.95M | $1.0M | 1.50% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 1.33M | $1.0M | 1.02% | -38.0K | 2026-06-30 |
| Deer Management Co. LLC | 1.25M | $1.0M | 0.96% | -- | 2026-06-30 |
| Millennium Management LLC | 1.16M | $1.0M | 0.90% | -296.7K | 2026-06-30 |
| Jacobs Levy Equity Management, Inc | 1.05M | $1.0M | 0.81% | +241.4K | 2026-06-30 |
| Citadel Advisors LLC | 1.01M | -- | 0.78% | +690.7K | 2026-06-30 |
